This site is intended for healthcare professionals only
LoginRegister

Medicine Dialogues

Semaglutide and Tirzepatide May Lower Dementia, Stroke, and Death Risk in Diabetic Patients With Obesity: Study

Semaglutide and Tirzepatide May Lower Dementia, Stroke, and Death Risk in Diabetic Patients With...

Taiwan: A large-scale cohort study published in JAMA Network Open suggests that the use of GLP-1 receptor agonists, specifically semaglutide and...
View All

Latest News and Guidelines

Lung TB: Higher dose of rifampicin safe, can boost recurrence-free survival, says ICMR study

Lung TB: Higher dose of rifampicin safe, can boost recurrence-free survival, says ICMR study

Abelacimab Shows Low Bleeding Risk During Procedures in AF Patients: AZALEA-TIMI 71 Trial

Abelacimab Shows Low Bleeding Risk During Procedures in AF Patients: AZALEA-TIMI 71 Trial

Endocrine Societies Release Joint Recommendations for Safer Pregnancies in Women With Diabetes

Endocrine Societies Release Joint Recommendations for Safer Pregnancies in Women With Diabetes

Struggling with Sleep? These Exercises Might Be Better Than Pills: Study Suggests

Struggling with Sleep? These Exercises Might Be Better Than Pills: Study Suggests

Risk for GERD higher with GLP-1 RA use compared to SGLT-2 inhibitor use: Study

Risk for GERD higher with GLP-1 RA use compared to SGLT-2 inhibitor use: Study

Anticholinergic Use Linked to Faster Physical Decline in Older Adults, finds research

Anticholinergic Use Linked to Faster Physical Decline in Older Adults, finds research

View All
X